One has to wonder who checks the costing that Novartis uses to justify the price of its Kymriah Cancer Drug. What would Robert Koch, Louis Pasteur or Alexander Fleming make of this behaviour?
https://www.bloomberg.com//news/articles/2017-08-30/cancer-breakthrough-heralds-new-era-of-cures-costs-and-choices
History for the Books: Javier Milei & Argentina’s Budget
-
For most of 2023, Javier Milei advocated a number of libertarian policies
aimed at reversing Argentina’s long economically downward trend. Among them
was...
9 hours ago
No comments:
Post a Comment